Mechanism of interleukin-13 production by granulocyte-macrophage colony-stimulating factor-dependent macrophages via protease-activated receptor-2

Blood Cells Mol Dis. 2015 Jun;55(1):21-6. doi: 10.1016/j.bcmd.2015.03.006. Epub 2015 Mar 30.

Abstract

Background: Granulocyte-macrophage colony-stimulating factor (GM-CSF) promotes classically activated M1 macrophages. GM-CSF upregulates protease-activated receptor-2 (PAR-2) protein expression and activation of PAR-2 by human neutrophil elastase (HNE) regulates cytokine production.

Aim: This study investigated the mechanism of PAR-2-mediated interleukin (IL)-13 production by GM-CSF-dependent macrophages stimulated with HNE.

Methods: Adherent macrophages were obtained from primary cultures of human mononuclear cells. After stimulation with HNE to activate the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway, IL-13 mRNA and protein levels were assessed by the reverse transcriptase-polymerase chain reaction and enzyme-linked immunosorbent assay, respectively.

Results: PAR-2 protein was detected in GM-CSF-dependent macrophages by Western blotting. Unexpectedly, PD98059 (an ERK1 inhibitor) increased IL-13 production, even at higher concentrations. Interestingly, U0126 (an ERK1/2 inhibitor) reduced IL-13 production in a concentration-dependent manner. Neither SB203580 (a p38alpha/p38beta inhibitor) nor BIRB796 (a p38gamma/p38delta inhibitor) affected IL-13 production, while TMB-8 (a calcium chelator) diminished IL-13 production.

Discussion: Stimulation with HNE promoted the production of IL-13 (a Th2 cytokine) by GM-CSF-dependent M1 macrophages. PAR-2-mediated IL-13 production may be dependent on the Ca(2+)/ERK2 signaling pathway.

Keywords: Extracellular signal-regulated kinase; Granulocyte-macrophage colony-stimulating factor; Interleukin-13; Neutrophil elastase; Protease-activated receptor-2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Butadienes / pharmacology
  • Calcium / metabolism*
  • Calcium Channel Blockers / pharmacology
  • Cell Adhesion
  • Cell Differentiation / drug effects
  • Dose-Response Relationship, Drug
  • Flavonoids / pharmacology
  • Gallic Acid / analogs & derivatives
  • Gallic Acid / pharmacology
  • Gene Expression Regulation
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology*
  • Humans
  • Imidazoles / pharmacology
  • Interleukin-13 / genetics*
  • Interleukin-13 / immunology
  • Leukocyte Elastase / pharmacology
  • Macrophages / cytology
  • Macrophages / drug effects*
  • Macrophages / immunology
  • Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 1 / genetics
  • Mitogen-Activated Protein Kinase 1 / immunology*
  • Mitogen-Activated Protein Kinase 3 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 3 / genetics
  • Mitogen-Activated Protein Kinase 3 / immunology
  • Monocytes / cytology
  • Monocytes / drug effects
  • Monocytes / immunology
  • Naphthalenes / pharmacology
  • Nitriles / pharmacology
  • Primary Cell Culture
  • Protein Kinase Inhibitors / pharmacology
  • Pyrazoles / pharmacology
  • Pyridines / pharmacology
  • Receptor, PAR-2 / genetics*
  • Receptor, PAR-2 / immunology
  • Signal Transduction
  • p38 Mitogen-Activated Protein Kinases

Substances

  • Butadienes
  • Calcium Channel Blockers
  • Flavonoids
  • IL13 protein, human
  • Imidazoles
  • Interleukin-13
  • Naphthalenes
  • Nitriles
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyridines
  • Receptor, PAR-2
  • U 0126
  • 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate
  • Gallic Acid
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • MAPK1 protein, human
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • p38 Mitogen-Activated Protein Kinases
  • Leukocyte Elastase
  • doramapimod
  • SB 203580
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
  • Calcium